Oruka Therapeutics to Present at the Jefferies Global Healthcare Conference

Rhea-AI Summary

Oruka Therapeutics (Nasdaq: ORKA), a clinical-stage biotech company focused on developing novel biologics for chronic skin diseases including plaque psoriasis, has announced its participation in the upcoming Jefferies Global Health Care Conference. The presentation is scheduled for Wednesday, June 4th, 2025, at 12:50 PM ET in New York. Investors and interested parties can access the presentation webcast and replay through Oruka's investor events website at ir.orukatx.com.

News Market Reaction – ORKA

-0.38%

-0.38% Session move

In the trading session that priced this news, ORKA declined 0.38%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MENLO PARK, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced a presentation at the Jefferies Global Health Care Conference in New York, NY:

Date: Wednesday, June 4^th, 2025
Time: 12:50PM ET

A webcast and replay of Oruka’s presentation will be available on the Oruka investor events website at https://ir.orukatx.com/news-events/events-presentations.

About Oruka Therapeutics

Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as once or twice a year. Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. For more information, visit www.orukatx.com and follow Oruka on LinkedIn.

Investor Contact: 
Alan Lada 
(650)-606-7911 
alan.lada@orukatx.com 

FAQ

When is Oruka Therapeutics (ORKA) presenting at the Jefferies Healthcare Conference 2025?

Oruka Therapeutics (ORKA) is presenting at the Jefferies Global Healthcare Conference on Wednesday, June 4th, 2025, at 12:50 PM ET in New York.

What diseases is Oruka Therapeutics (ORKA) developing treatments for?

Oruka Therapeutics is developing novel biologics for the treatment of chronic skin diseases, including plaque psoriasis.

How can investors watch Oruka Therapeutics' (ORKA) Jefferies conference presentation?

Investors can access the webcast and replay of Oruka's presentation through the company's investor events website at ir.orukatx.com/news-events/events-presentations.

What stage of development is Oruka Therapeutics (ORKA) currently in?

Oruka Therapeutics is currently a clinical-stage biotechnology company.